Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Point Biopharma And Advancell To Collaborate In The Development Of Lead-212-Labeled Radioligands

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    26/06/2023 13:15
    June 26 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA AND ADVANCELL TO COLLABORATE IN THE
DEVELOPMENT
OF LEAD-212-LABELED RADIOLIGANDS
    * POINT BIOPHARMA GLOBAL INC - TERMS WERE NOT DISCLOSED

Source text for Eikon:  ID:nGNX72kV71 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on POINT Biopharma Global

    See all news